NCT00555438 - Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux. | Biotech Hunter

Enrollment

451

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions

Major Orthopaedic Surgery and Renal Impairment

Interventions

DRUG

fondaparinux 1.5 mg/day

Subcutaneous injection of fondaparinux 1.5 mg/l after major orthopaedic surgery

Trial Locations (29)

14000

PEGOIX Michel, Caen

21079

LETOURNEAU Bernard, Dijon

30029

RIPART Jacques, Nîmes

31059

FUZIER Régis, Toulouse

33000

SZTARCK François, Bordeaux

34295

CAPDEVILLA Xavier, Montpellier

37044

COUVRET Claude, Tours

42013

BAYLOT Denis, Saint-Etienne

44200

PERON Alain, Nantes

47000

GARANGER Thierry, Agen

51092

BARRE Jeanne, Reims

59880

DUVERGER Daniel, Saint-Saulve

63000

SCHOEFFLER Pierre, Clermont-Ferrand

64109

BONNEMAISON Julie, Bayonne

69006

CHAMBON Françoise, Lyon

69437

BEGOU Gérard, Lyon

72000

LEMANISSIER Denis, Le Mans

75013

LANGERON Olivier, Paris

75014

RABUEL Christophe, Paris

75679

MAZUIRE Elisabeth, Paris

76031

LIGNOT Sophie, Rouen

79006

CHEVALEREAUD Erick, Niort

85016

TISSIER Dominique, La Roche-sur-Yon

86035

THERY Philippe, Poitiers

92140

AUSSET Sylvain, Clamart

93009

BELLOUCIF Sadek, Bobigny

07100

CHARRET Françoise, Annonay

06200

GAERTNER Elisabeth, Nice

42 055

MARTIN, Saint-Etienne